title: Quality of life and behavioral functioning in Dutch pediatric patients with hereditary spherocytosis.
abstract: The objective of this study was to evaluate health-related quality of life (HRQoL) and behavioral functioning in pediatric patients with hereditary spherocytosis (HS). A cross-sectional study was conducted in 132 Dutch children and adolescents with HS and aged 8-18 years of whom 48 underwent splenectomy prior to the study. HRQoL was assessed using the KIDSCREEN-27, and behavioral functioning was evaluated using the strength and difficulties questionnaire (SDQ). Scores of pediatric patients with HS were compared to a Dutch norm population. Additionally, the effects of three factors were assessed: fatigue, self-image, and parents' perceived vulnerability (measured with the checklist individual strength, the self-perception profile for children and adolescents, and the child vulnerability scale). Both unsplenectomised and splenectomised pediatric patients reported lower HRQoL on the domain physical well-being (KIDSCREEN-27) compared to Dutch peers. For behavioral functioning, parents of both groups reported more emotional problems (SDQ) compared to the norm population. Pediatric patients with lower scores on physical well-being experienced more fatigue. The patients' perceived social acceptance and parents' perceived vulnerability appeared as determinants of emotional problems.
  
  
  CONCLUSIONS
  Pediatric patients in the current study generally report few complaints, and the results suggest that these patients overall have a strong ability to cope with HS. Despite these few complaints, fatigue and parents' perceived vulnerability seem to be important determinants for lower HRQoL and more emotional problems. Therefore, screening on these factors could serve as an addition to the treatment of HS, to help pediatric patients who are at risk for lower HRQoL or more emotional problems.
authors.affiliation: Psychosocial Department, Emma Children's Hospital, Academic Medical Center, Amsterdam, The Netherlands.
authors.forename: Myra
authors.initials: M
authors.lastname: Teunissen
authors.forename: Channa T
authors.initials: CT
authors.lastname: Hijmans
authors.forename: Marjon H
authors.initials: MH
authors.lastname: Cnossen
authors.forename: Madelon B
authors.initials: MB
authors.lastname: Bronner
authors.forename: Martha A
authors.initials: MA
authors.lastname: Grootenhuis
authors.forename: Marjolein
authors.initials: M
authors.lastname: Peters
mesh_terms: D000223:Adaptation, Psychological; D000293:Adolescent; D000294:Adolescent Behavior; D017487:Ankyrins / Q000172:deficiency*; D002648:Child; D002652:Child Behavior; D003430:Cross-Sectional Studies; D005221:Fatigue / Q000523:psychology; D005260:Female; D006304:Health Status; D006801:Humans; D008297:Male; D009426:Netherlands; D010290:Parents / Q000523:psychology*; D011788:Quality of Life; D012944:Social Support; D013103:Spherocytosis, Hereditary / Q000523:psychology*; D011795:Surveys and Questionnaires
chemical_list: D017487:Ankyrins
references.citation: Eur J Surg. 2001 Jan;167(1):23-8
references.pmid: 11213816
references.citation: Br J Haematol. 2012 Jan;156(1):37-49
references.pmid: 22055020
references.citation: J Infect. 2001 Oct;43(3):182-6
references.pmid: 11798256
references.citation: J Pediatr Psychol. 1996 Feb;21(1):89-101
references.pmid: 8820075
references.citation: Eur Child Adolesc Psychiatry. 2003 Dec;12(6):281-9
references.pmid: 14689260
references.citation: J Pediatr Psychol. 2003 Apr-May;28(3):185-90
references.pmid: 12654943
references.citation: J Nerv Ment Dis. 2002 Jun;190(6):388-93
references.pmid: 12080209
references.citation: J Pediatr Psychol. 2000 Jul-Aug;25(5):287-99
references.pmid: 10880059
references.citation: Eur Child Adolesc Psychiatry. 2003 Jan;12(1):1-8
references.pmid: 12601558
references.citation: Support Care Cancer. 1998 Mar;6(2):101-8
references.pmid: 9540167
references.citation: J Child Psychol Psychiatry. 1998 Jan;39(1):29-46
references.pmid: 9534085
references.citation: Value Health. 2008 Jul-Aug;11(4):645-58
references.pmid: 18179669
references.citation: J Spec Pediatr Nurs. 2007 Apr;12(2):105-14
references.pmid: 17371554
references.citation: BMJ. 2001 Sep 1;323(7311):480-4
references.pmid: 11532838
references.citation: Health Technol Assess. 2001;5(4):1-157
references.pmid: 11262421
references.citation: HIV Clin Trials. 2007 Sep-Oct;8(5):320-7
references.pmid: 17956833
references.citation: Br J Haematol. 2009 Jun;145(6):728-32
references.pmid: 19388926
references.citation: Lancet. 2008 Oct 18;372(9647):1411-26
references.pmid: 18940465
references.citation: Blood. 2001 Jan 15;97(2):399-403
references.pmid: 11154215
references.citation: Pediatr Blood Cancer. 2008 Aug;51(2):269-74
references.pmid: 18454464
references.citation: J Psychosom Res. 1994 Jul;38(5):383-92
references.pmid: 7965927
references.citation: J Dev Behav Pediatr. 1995 Aug;16(4):251-6
references.pmid: 7593660
references.citation: Blood. 1993 Apr 15;81(8):2014-20
references.pmid: 8471763